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Cassava is an important staple crop in sub-Saharan africa. Between 1970 and 2007, its production and acreage tripled across africa and quadrupled in nigeria, the continent’s and the world’s largest producer (fao, 00). Sub-
 Saharan africa produced over  million tons of fresh roots of cassava in 00, of which 
no less than 95% was consumed as food; the starch provides >5% of dietary energy for 
an estimated 00 million africans (Dorosh, 00). frequent consumers of cassava are at 
greater risk for malnutrition—especially deficiencies in vitamin-a, iron, and zinc—than 
consumers of other diets, particularly those that are cereal-based (Gegios et al., 00). a 
nutrition survey in cassava-consuming areas of nigeria and Kenya revealed inadequate 
intake of vitamin a in 3% and % and inadequate iron intake in 3% and % of 
pre-school-aged children, respectively (Gegios et al., 00). vitamin-a deficiency causes 
a loss of 9,000 disability-adjusted life years (DaLYs1) in nigeria and ,000 DaLYs 
in Kenya annually; iron deficiency causes loss of 59,000 DaLYs in nigeria and 03,000 
DaLYs in Kenya (fielder, 009). 
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1a measure of overall disease burden, expressed as the number of years lost due to ill-health, disability or early 
death.
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Current efforts to combat micronutrient deficiencies in africa include supplementation, 
through distribution of micronutrients to high-risk populations, addition to processed 
food and biofortification, i.e. the genetic improvement of nutrient content of crops via 
field-based breeding or genetic engineering. Supplementation requires tremendous effort 
to exceed 90% coverage and must be sustained for many years (Berti and rowley 00); 
few countries in africa are able to run effective supplementation programs. Biofortification, 
on the other hand, can achieve 00% penetration and, although it requires a substantial 
initial investment in research and dissemination, it is self-sustaining. Cost per DaLY saved 
for biofortification is 0% less compared to supplementation (nestel et al., 00).
BioCassava Plus (BC+) is a cassava-biofortification project at the Donald Danforth 
Center in St. Louis, Mo, funded by the Bill and Melinda Gates foundation. BC+ 
scientists are engineering cassava for increased accumulation of β-carotene, iron, and 
protein to provide minimum daily allowances of these essential nutrients as a means of 
ameliorating the burden of malnutrition that accompanies consumption of cassava as a 
staple food. Proof of concept for the enrichment of these nutrients has been demonstrated 
in the model cassava cultivar 0, which, in greenhouse and confined field trials in 
Puerto rico, contains up to 0 µg/g dry weight (Dw) of β-carotene (provitamin a), 0 
µg/g dry weight of iron, 0% protein storage roots, and reduced levels of anti-nutritional 
cyanogens.
Biofortification of Cassava
β-carotene 
β-carotene enrichment of storage roots in cassava is conferred by two transgenes: the 
Erwinia crtB phytoene-synthase gene, and the Arabidopsis -deoxyxylulose-5-phosphate 
synthase (DXS) gene. The crtB transgene includes a 0.-kb sequence for the plastid 
transit peptide for the Δ-palmitoyl-acyl carrier protein desaturase from coriander. The 
phytoene synthase encoded by the crtB gene catalyzes the committed step in β-carotene 
synthesis using geranylgeranyl-diphosphate (GGDP) from the plastid isoprenoid pathway 
as its substrate. DXS catalyzes the first step in the plastid isoprenoid pathway. Increased 
expression of this enzyme is intended to enhance concentrations of GGDP for β-carotene 
synthesis and also to ensure sufficient amounts of GGDP to maintain vitamin-e produc-
tion at or above wild-type levels. The crtB and DXS genes are each under the control of 
the Solanum tuberosum (potato) patatin promoter and flanked on their 3’ ends by the 
3’ untranslated region (Utr) of the nopaline synthase (nos) gene from Agrobacterium 
tumefaciens. The selectable marker is the neomycin phosphotransferase II (nptII) from E. 
coli under control of the cauliflower mosaic virus 35S (CaMv 35S) promoter (with x 
enhancer). The nptII gene is flanked on its 3’ end by the CaMv 35S 3’ Utr.
Plants expressing the crtB and DXS genes were initially evaluated in four-inch pots 
under greenhouse conditions. amounts of total carotenoids ranged from 30 to 0 µg/g 
Dw in storage roots of the top lines. By comparison, amounts of total carotenoids in 
storage roots of control 0 plants in these and subsequent greenhouse and field studies 
ranged from .5 to .5 µg/g Dw. Subsequent evaluations were conducted of storage roots 
of plants growing in soil beds in the greenhouse and in confined field trials in Puerto rico. 
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Concentrations of total carotenoids in roots from greenhouse beds typically ranged from 
30 to 5 µg/g Dw. Concentrations of carotenoids from the confined field studies ranged 
from 30 to 0 µg/g Dw. Concentrations of vitamin e were not significantly different 
between storage roots from the top β-carotene lines and non-transformed controls. In 
the transformed lines, the relative amounts of all-trans-β-carotene, the most nutrition-
ally efficacious form of carotenoid provitamin a, were 5 to 90% of the total carotenoid 
content. relative amounts of trans-β-carotene in non-transformed controls were only 50 
to 0% of the total carotenoid content. In collaboration with partners in africa, BC+ has 
confined field trials of the β-carotene-enriched GM events (i.e. transformed plant lines) 
ongoing in nigeria and another trial is planned for fall 00 in Kenya.
In addition to the consumer benefit of improved nutrient levels, BC+ β-carotene-
rich GM events also have producer benefits in terms of extended shelf-life. five of the 
events with the highest amounts of total carotenoids could be stored for up to  days 
after harvest, whereas the wild-type recorded up to 0% spoilage after  days. reduced 
shelf-life of cassava roots, a result of post-harvest physiological deterioration (PPD), is a 
major limitation to marketing of fresh roots. PPD begins  hours after harvest and can 
render the roots unpalatable and unmarketable within  hours. Short shelf-life affects 
cassava value-added chains because it increases losses during processing and limits access 
to markets distant from production sites. Longer shelf-life was correlated with total ca-
rotenoid content (r = 0.0) in the GM events, which is consistent with previous studies 
indicating that high levels of carotenoids in the roots (>  ppm fresh weight basis) delay 
PPD (Sanchez et al., 005).
nutrient retention during food preparation was also evaluated in three transgenic lines 
expressing higher levels of β-carotene. In three common nigerian food preparations—gari, 
fufu and boiled—retention of provitamin a ranged from % to 3%, equal to, or bet-
ter than, that seen in the wild-type 0 variety. values for in vitro bioavailability of 
provitamin a, as measured by uptake into micelles of Caco human intestinal cells, were 
similar for the transgenic and wild-type sources, i.e. % and 3%, respectively.
Iron 
Increased iron content was achieved by the expression of the FEA1 gene, from Chlam-
ydomonas reinhardtii, in cassava storage roots. The fea protein is an iron-specific metal 
transporter. It transfers iron efficiently at very low concentrations or at high pHs at which 
iron is largely insoluble. It does not transport toxic heavy metals unlike all other known 
metal transporters in plants. as with the β-carotene trait, FEA1 expression was driven by 
the patatin promoter and nos terminator. Seven GM events were tested in the greenhouse 
and in confined field trials in Puerto rico; iron content in the GM events ranged from 
30 to 0 µg/g Dw in storage roots compared to 0 µg/g dry weight in the wild type. 
real-time PCr analyses strongly suggest that the additional iron is stored as a ferritin 
complex in the transgenic plants.
The morphology, including branching and flowering, of transgenic plants was identical 
to that of wild-type plants in Puerto rico.
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Protein
Increased protein content in cassava was achieved by the expression of sporazein, a stor-
age fusion protein consisting of a 0-bp fragment of β-zein from maize, the sporamin 
gene from sweet potato and a 50-bp fragment of β-zein. Sporazein is a nutritionally 
balanced protein of 9. kD in which the zein components drive accumulation of the 
product to form protein bodies within the endoplasmic reticulum. as with the other two 
traits, the patatin promoter and nos terminator drive sporazein accumulation in cassava 
storage roots. 
Seven GM events expressing sporazein were tested in the greenhouse, in soil beds, and 
in confined field trials in Puerto rico. total protein content of storage roots harvested 
ranged from 9 to % Dw across all seven transgenic lines studied. The morphology 
and growth habit of these transgenic plants have shown no significant differences to 
non-transgenic controls in all three locations tested to date. no changes in expression 
of trait accumulation have been observed over the  months during which these plants 
have been tested in the greenhouse and field. as protein bodies are water-insoluble, water 
soaking overnight at room temperature resulted in 9% retention of the total protein 
content of the cassava roots. Boiling for 30 min resulted in 95% retention of the total 
protein content.
It is well known from other plant systems that the direction of reduced nitrogen to 
the synthesis of new proteins may come at the expense of nitrogen allocation to essential 
proteins required for metabolism. Thus, elevating expression of storage proteins in cassava 
may impair the growth or biochemical properties of roots. to address this concern, we have 
over-expressed a vacuolar targeted linamarase, an enzyme that breaks down linamarine, 
a cyanogenic glucoside found in cassava leaves, stems, and roots. This has been shown to 
increase the pool sizes of free amino acids in cassava.
Product Development of nutrient-enriched Cassava for africa
BC+ has achieved nutrient enrichment of cassava such that if a 5-year-old child con-
sumes 00 g/day of roots from the β-carotene, iron, or protein-rich GM events, (s)he 
will obtain 00% of the minimum daily allowance (MDa) of these nutrients. BC+ has, 
therefore, embarked on the expression of genes for the aforementioned nutritional traits 
in farmer-preferred cassava varieties from nigeria and Kenya, its two target countries. 
Genetic transformations at the Donald Danforth Plant Science Center (DDPSC) have 
successfully generated transgenic lines of oko-Iyawo, the most popular nigerian variety 
of cassava currently grown on  to % of total acreage (about  million hectares) in 
that country, and the Kenyan cultivar Serere.
Based on ex-ante impact studies for nutrient deficiency in Kenya and nigeria, a 
β-carotene- and iron-enriched oko-Iyawo for nigeria, and a β-carotene-, iron- and 
protein-enriched, and virus-resistant, Serere for Kenya were selected as first products. 
oko-Iyawo is resistant to cassava mosaic disease (CMD), which is of viral origin and is 
the principal production constraint of cassava in africa, whereas Serere is susceptible to 
CMD and needs to be engineered for resistance. Product development is divided into 
several stages, namely:
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• generation of transgenic events,
• greenhouse characterization and testing,
• field testing,
• selection of a lead event,
• food and environmental safety assessments in a regulatory field trial,
• biosafety approval for commercial release,
• on-farm trials, and finally 
• variety release and dissemination. 
Lead Event Selection
a commercial quality construct that is codon-optimized without extraneous genetic 
elements, will be created for the crtB, DXS, FEAI genes (β-carotene and iron traits) 
and transformed into friable embryogenic callus derived from oko-Iyawo. Six hundred 
transgenic plants will be regenerated and screened for events that possess a single copy 
of the construct, no vector backbone sequences and good rna expression. events, an 
estimated 5, that meet these criteria will be planted in the greenhouse and roots evalu-
ated for β-carotene and iron contents. events that meet the set targets of 0 µg/g Dw 
for the two traits will be transferred to confined trials in Puerto rico and nigeria for 
trait assessment under field conditions. This will be followed by two cycles of replicated 
confined field trials at three locations to select a lead event and a back-up for regulatory 
trials. a similar procedure will be followed for the Kenyan product, with the exception 
that the gene construct will contain sporazein and rnai for CMD and cassava brown 
streak disease (CBSD), a viral disease of cassava that is specific to east africa. 
Biosafety Regulatory Activities
Cultivation and consumption of cassava expressing these genes will require the granting 
of approval from regulatory bodies in nigeria, based upon food and environmental safety 
assessments of each novel gene/protein that confers the targets traits. a safety assessment 
is required for each event intended for commercial release. DXS, crtB, FEA1, sporazein, 
and npt II proteins will be purified, characterized, and assessed for potential toxicity in 
acute (single dose) oral gavage studies with mice. allergenicity of the DXS, crtB, and FEA1 
proteins will be assessed in accordance with international guidelines. This is a ‘weight of 
evidence’ assessment that includes the source of the gene, documented dietary exposure to 
the protein, any amino-acid sequence homology to known allergens, and protein stability 
upon incubation in simulated gastric fluid. 
The purified proteins will also be used to develop western blot and enzyme-linked im-
munosorbent assays for detection of the proteins in plant material. as the DXS and crtB 
proteins are enzymes and will be present at higher levels than what are typical in cassava, 
regulatory authorities will likely require information on substrate specificity. evidence 
from the peer-reviewed literature on known substrate specificity for these enzymes will 
be sought.
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a key consideration of regulators is assessment of any unintended effects that result 
from elevated biosynthesis of metabolites in the carotenoid biosynthetic pathway. Unin-
tended effects are traditionally addressed in the safety assessment by performing extensive 
nutrient-composition and agronomic performance analyses. Compositional analyses of 
starch quantity and quality, fatty acids, total and free amino acids, minerals, vitamins, 
cyanogenic glucosides and phytates will be conducted. Protocols for the compositional 
and agronomic regulatory field trials—a final field trial conducted on a lead event to 
generate agronomic performance, food and environmental safety information—will be 
in accordance with international guidelines.
Reaching End-Users
agricultural development in africa is replete with examples of well intended scientific 
advances that have had limited impact because they were not sustainably adopted by 
producers and consumers. fortunately, there are also excellent examples of widespread 
successful adoption of new varieties. The strategy to reach end-users should avoid the 
mistakes of the former and build on the successes of the latter, while taking into account 
the special issues associated with transgenic varieties. Many failures have resulted from 
a narrow focus on preferred production characteristics. a critical aspect important for 
reaching end-users is seed production and distribution. In africa, the vast majority of 
cassava stakes for planting is generated from current plants by the farmer or obtained from 
neighbors; the private sector has little interest in this crop. However, non-government 
organizations (nGos) involved in development activities and some national agricultural 
systems now have good experience with dissemination of new varieties. BC+ will partner 
with organizations that have the best linkages to large numbers of farmers. tissue culture 
and an inexpensive two-node multiplication system for rapid and massive propagation 
will be used to bulk up foundation seed for distribution to large nGos and government 
agencies.
Cost-effective strategies for farmer adoption and consumer acceptance of β-carotene 
and iron-rich cassava entail a marketing and promotion plan. for example, gari is the 
most important food staple of the rural and urban poor and the gari market chains have 
extensive coverage; over 0% of cassava grown in nigeria is used for gari production. a 
great advantage is that the deep yellow color of high-β-carotene and -iron cassava is similar 
to a yellow gari product, made by addition of palm oil, already accepted by consumers. 
although gari processing tends to lead to a depletion of β-carotene and iron, levels of 
nutrient enrichment achieved in BC+ ensure that sufficient amounts of these nutrients 
remain to meet minimum daily allowances based on the average quantity consumed and 
bioavailability.  
anti-GMo nGos may be expected to mount campaigns in opposition to dissemina-
tion and adoption of β-carotene- and iron-enriched cassava. opposition can be overcome 
through demonstration of the benefits to consumers (improved nutritional quality) and 
to producers/processors (extended shelf life of storage roots). other elements for coun-
tering such opposition include: adhering strictly to bio-safety protocols and regulatory 
requirements; being transparent by engaging key stakeholders in constant dialogue to 
communicate progress and building confidence that the process is being properly and 
